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During August 2010–December 2012, we conducted a 
study of patients in Ghana who had Buruli ulcer, caused 
by Mycobacterium ulcerans, and found that 23% were co-
infected with Mansonella perstans nematodes; 13% of con-
trols also had M. perstans infection. M. perstans co-infec-
tion should be considered in the diagnosis and treatment 
of Buruli ulcer.
Buruli ulcer, caused by Mycobacterium ulcerans, is a neglected tropical disease common in rural parts of 
West Africa. Infection with M. ulcerans causes disfigur-
ing skin ulcers, mainly in children. The disease is highly 
focal, and in Ghana, cases are reported mainly from the 
humid and tropical southern regions, including Ashanti and 
Greater Accra (1). Recent studies suggest that aquatic in-
vertebrates serve as a reservoir for M. ulcerans, although 
complete transmission pathways remain unknown (2,3). 
Aquatic insects infected with M. ulcerans can establish 
infection in mice by biting (4), but it is not clear that this is 
the cause of human infection (5). In southeastern Australia, 
evidence has been found linking infected mosquitoes with 
human cases (6,7), but proof of transmission is lacking.
Residents of regions in which Buruli ulcer is endemic 
are frequently exposed to parasitic infections such as fila-
riasis. In Ghana, lymphatic filariasis caused by Wuchereria 
bancrofti nematodes is found in several regions to which 
Buruli ulcer is endemic, such as the Upper Denkyira Dis-
trict in the central region of Ghana, but its prevalence is 
unknown (8). The filarial nematode Mansonella perstans 
is endemic to countries in central and western Africa; its 
distribution overlaps that of other filarial nematodes W. 
bancrofti, Loa loa, and Onchocerca volvulus (9). Infec-
tive M. perstans larvae are transmitted through the bite of 
Culicoides midges (Diptera: Ceratopogonidae); the larvae 
develop over the course of months into adult worms that 
reside in serous cavities, particularly in the abdomen. M. 
perstans infection is not associated with a specific set of 
clinical signs and symptoms, but those attributed to this in-
fection include acute swelling in the forearms, hands, and 
face that recedes in a few days and often recurs; itching 
with or without rash; arthralgia; and eosinophilia (9).
During an investigation into the immunopathogenesis 
of Buruli ulcer, we observed M. perstans nematodes in 
preparations of peripheral blood mononuclear cells from a 
patient. This finding led us to consider whether this organ-
ism was involved in the transmission or pathogenesis of 
M. ulcerans disease or if the finding was incidental. We 
then conducted a small case–control study to investigate 
the frequency of M. perstans co-infection in patients with 
M. ulcerans disease and the effect of this co-infection, if 
any, on patient response to antimicrobial drug therapy.
The Study
During August 2010–December 2012, we recruited all 
patients who had clinically suspected M. ulcerans infection 
and had attended a clinic in the Buruli ulcer–endemic As-
ante Akim North District in Ghana. Age- and sex-matched 
household contacts of patients were also asked to partici-
pate; all study participants were >5 years of age. The study 
protocol was approved by the ethics review committee of 
the School of Medical Sciences, Kwame Nkrumah Univer-
sity of Science and Technology (CHRPE/91/10).
Whole blood samples were taken at baseline, at week 
6, and at week 12 from 66 patients in whom the diagno-
sis of Buruli ulcer disease had been confirmed by PCR for 
the IS2404 repeat sequence specific for M. ulcerans (8); 
samples were also obtained from 20 household contacts at 
the same intervals. The samples were heparinized, and pe-
ripheral blood mononuclear cells were separated from 10-
mL samples. Filarial infection was confirmed on a blood 
film stained with Giemsa and Delafield hematoxylin and 
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examined for microfilariae at ×10 and ×40 magnification 
(the Knott technique; 10). M. perstans nematodes were dis-
tinguished from L. loa and W. bancrofti nematodes by their 
small size and the absence of a sheath (Figure 1). 
Patients in whom M. ulcerans infection was found were 
treated with 10 mg/kg oral rifampin and 15 mg/kg intra-
muscular streptomycin, administered daily at village health 
posts under direct observation for 8 weeks (RS8 treatment). 
The patients were followed up every 2 weeks in the clinic 
and monitored for complete healing or recurrence of skin 
lesions. We compared the proportion of household controls 
versus the proportion of Buruli ulcer patients infected with 
M. perstans nematodes and the time to complete healing of 
M. ulcerans lesions in co-infected versus monoinfected pa-
tients. Categorical variables such as sex, clinical form of M. 
ulcerans lesion, and category of M. ulcerans lesion were 
compared by using the Fisher exact test, and cumulative 
healing was compared by using the log-rank test.
We found all forms of M. ulcerans disease among the 
group of patients; proportions of each type and category 
are shown in the Table. Of 66 patients with M. ulcerans 
disease, 15 (22.7%) were co-infected with M. perstans 
nematodes, whereas 4 (13%) of 30 household controls had 
M. perstans infection (p = 0.4 by Fisher exact test). Three 
patients in the co-infected group and none in the M. ulcer-
ans–monoinfected group reported pruritus. No other clini-
cal signs of M. perstans infection were found.
All 66 patients completed RS8 treatment, but 9 were 
lost to follow-up during the 12-month follow-up period. 
Buruli ulcer lesions healed completely in 14 co-infected 
patients by 58 weeks (median 20 weeks, 95% CI 14.6–
30.2) and in 43 monoinfected patients by 50 weeks (me-
dian 21 weeks, 95% CI 16.7–25.5). We found no differ-
ence in cumulative time to healing for co-infected versus 
monoinfected patients (p>0.05 by log-rank test) (Figure 
2). Buruli ulcer patients who had M. perstans nematodes 
co-infection were treated with doxycycline (200 mg) and 
ivermectin (150 μg/kg) daily for 6 weeks, starting during 
the second to fourth week of RS8 treatment. Viable micro-
filariae were still visible in peripheral blood mononuclear 
cell cultures from all co-infected patients after ivermectin 
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Table.	Characteristics	of	patients	with	active	Mycobacterium ulcerans infection, monoinfected or co-infected with Mansonella perstans, 
and of household contacts, Ghana, August 2010–December 2012* 
Characteristic 
No.	(%)	persons	with	M. ulcerans infection 
No.	(%)	household	
contacts, n = 30 p	value 
Co-infected with M. 
perstans,	n	=	15 Monoinfected,	n	=	51 Total, n	=	66 
Age, y     0.514† 
 <16 4	(27) 24	(47) 28	(42) 15	(50)  
 16–59 11	(73) 27	(53) 38	(58) 15	(50)  
Sex     1.000† 
 M 9	(60) 19	(37) 30 (45) 14	(47)  
 F 6	(40) 32	(63) 36	(55) 16	(53)  
Clinical form of M. ulcerans 
infection 
    0.049‡ 
 
 Nodule 8	(53) 11	(22) 19	(29) NA  
 Plaque with edema 2	(12) 17	(33) 19	(29) NA  
 Ulcer 5	(35) 23	(45) 28	(42) NA  
Category of M. ulcerans 
infection 
    0.910‡ 
 I 9	(59) 32	(63) 41	(62) NA  
 II 4	(29) 11	(22) 15	(23) NA  
 III 2	(12) 8	(16) 10	(15) NA  
M. perstans infection     0.408‡ 
 Yes 15	(100) NA 15	(23) 4	(13)  
 No 0 NA 51	(77) 26	(87)  
*NA,	not	applicable. 
†Comparison of combined M. ulcerans monoinfected and M. ulcerans co-infected with M. perstans versus prevalence	in household contacts, determined 
by 2-tailed	Fisher	exact	test. 
‡Comparison of M. ulcerans co-infected with M. perstans versus	M. ulcerans monoinfected group, determined by 2-tailed	Fisher	exact	test. 
 
Figure	 1.	 Mansonella perstans nematode in peripheral blood 
mononuclear cells from Buruli ulcer patient in Ghana. Cells were 
stained	with	Giemsa	 (original	magnification	×1,000).	M. perstans 
nematodes can be distinguished from Loa loa and Wuchereria 
bancrofti	 nematodes	 by	 relative	 small	 size,	 detection	 in	 blood	
samples	obtained	during	the	day,	and	lack	of	a	sheath.	
and doxycycline treatment, but pruritus subsided in the 3 
patients who had reported it.
Conclusions
We found co-infection with M. perstans in 23% of Buruli 
ulcer patients in a disease-endemic district in Ghana, but this 
prevalence was not significantly difference from prevalence 
among household contacts who served as controls (13%). 
As with Buruli ulcer, M. perstans filariasis is predominantly 
found in rural populations and infection begins in childhood; 
the highest infection rates are found in children 10–14 years 
of age (11), similar to those for children at highest risk for 
M. ulcerans infection. M. perstans infection occurs in Ghana 
and was seen in the Volta region of Ghana around Hohoe 
during the 1990s, but its prevalence is unknown (12), and no 
information is available about the average number of worms 
per infection. In Uganda, prevalence of M. perstans infection 
has been found to range from 0.4% to 50% (13). 
M. perstans nematodes are transmitted by the bites of 
Culicoides midges, but it is not known whether M. per-
stans–infected midges can be co-infected with M. ulcerans. 
In a guinea pig model, skin penetration was shown to be a 
requirement for establishment of M. ulcerans disease (14), 
and it has been postulated that mosquito bites cause M. 
ulcerans disease in Australia (6). These organisms might 
share a common route of transmission, but our findings in 
this small study do not support this concept. 
Our findings suggest that M. perstans nematodes are 
common in rural Ghana and coincidentally infect patients 
with M. ulcerans disease, necessitating the consideration 
of these organisms in the management plan of Buruli ul-
cer patients. Although often asymptomatic, M. perstans 
infection may cause eosinophilia, subcutaneous swellings, 
aches, pains, and skin rashes in a considerable proportion 
of patients (9). Because filarial nematodes are known to po-
larize the host immune responses from T-helper type 1 cells 
needed for protection against mycobacterial infections, to-
ward humoral and T helper type-2 mediated immunity, we 
plan to undertake a study to investigate this interaction.
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